Lantig, Kevin Jay B.

HRN: 24-57-32  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/12/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
02/12/2024
02/18/2024
IVT
400mg
Q6
Urti
Waiting Final Action 
02/13/2024
CEFTRIAXONE 1G (VIAL)
02/13/2024
02/20/2024
IV
700mg
OD
PCAP-C
Waiting Final Action 
02/13/2024
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
02/13/2024
02/19/2024
PO
1ml
TID
Oral Ulcers
Waiting Final Action 
09/18/2025
CEFUROXIME 750MG (VIAL)
09/18/2025
09/25/2025
IV
370mg
Q8H
PCAP C
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: